Bone metastasis: mechanisms and therapeutic opportunities.
about
Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancerOestrogens and oestrogen receptors in prostate cancerBone site-specific delivery of siRNAMicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast DifferentiationNanomedicine applications in orthopedic medicine: state of the artAdvances in cancer pain from bone metastasisSmall-molecule SMAC mimetics as new cancer therapeuticsActivin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures.Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitorTumour-derived miRNAs and bone metastasisIdentification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone lossTargeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasisTreatment of osseous metastases using the Spinal Tumor Ablation with Radiofrequency (STAR) system.MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics.A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.Murine models of breast cancer bone metastasisThe role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data.Validation of algorithms to detect distant metastases in men with prostate cancer using routine registry data in Denmark.Bone-in-culture array as a platform to model early-stage bone metastases and discover anti-metastasis therapiesFluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy.ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.The best of both worlds - managing the cancer, saving the bone.Molecular regulation of bone marrow metastasis in prostate and breast cancerGalectin-3 inhibits osteoblast differentiation through notch signaling.Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models.WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone.Role of β-isomerized C-terminal telopeptides (β-CTx) and total procollagen type 1 amino-terminal propeptide (tP1NP) as osteosarcoma biomarkersHIF targets in bone remodeling and metastatic disease.Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.Treatment of Solitary Painful Osseous Metastases with Radiotherapy, Cryoablation or Combined Therapy: Propensity Matching Analysis in 175 Patients.Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods.Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal MetastasesDiagnostic value of bone-specific alkaline phosphatase in lung carcinoma patients with bone metastases: a meta-analysisP2X7 Receptor Function in Bone-Related Cancer.Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasisBone metastasis and the metastatic niche.Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells.Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts.
P2860
Q21132306-ADE59189-BFC5-4E20-8004-48229214D129Q26749122-B20534D9-37B3-4A36-92BE-ED6C9D7F9BE6Q26773973-5F7DBF97-AA76-4BB4-B852-6CBC944417D1Q26783571-4E2A7522-6AA0-42E5-88D4-30EEC94E4028Q26785640-2B86845E-F1C1-4883-B1B7-C2161F3A4BE3Q26796465-28CBE05E-B23D-4C62-9859-BFEACD75AC6DQ26864204-444AE6D7-8092-40EE-814B-AD475400EB8CQ27342550-2F01BFCA-C225-4B11-ABC9-0E14126494FEQ27676827-98196768-F97E-4E8E-AFCB-E1EC68E14D5BQ28086895-99B91F53-BD41-4013-8C91-D35E097E4FABQ28284818-23F86AA1-A24E-45E6-8229-38BF1BF5A6CEQ28546055-D6521EE6-B9B3-48E5-9FA7-2CF752B3B7D9Q28731449-F9D3F426-6E0F-4B48-B378-DCE39EABEB21Q30241914-51FFB0F0-A162-4DBD-83DF-F1FA15A84EF8Q30366633-608407BC-89BD-4370-B9EA-D6B1B843657FQ30504566-7C7E9E15-7BD6-4976-BFCC-BD147B057D73Q30828525-3BFA88D1-00BD-40EE-AA95-9A8D8F04B3C8Q30883662-78F6D87A-2B3B-4976-A7A4-8BCE143EC858Q30939971-E1E5442B-B033-4228-B2C9-679F5B107622Q33628894-049905EE-82B6-4E38-A2B2-23E48B78DEB3Q33715760-6FE92A67-5E97-4808-867F-2F604AE83E8DQ33739392-7925BB5F-42BC-46E9-8F5E-0DBF5EC44B34Q33920055-AF1DE748-5281-4D57-AFFD-D7F8190E9FA6Q34053030-D975CE7D-16B7-4C8F-8D84-8373CB27BC84Q34558900-334C7C0E-C3A6-4F0F-B77E-2C6CAFE4148CQ34580034-B4EE6C95-0AFD-4CCB-8D5B-5259CC507337Q34713778-D9432828-6B43-42E8-8E1E-4A4E99A6103DQ34971961-3ECEF8B8-8503-4629-A396-25A00F7A4756Q35173642-83872FC7-D487-4931-AC9F-3FBE0F2904AFQ35554344-98B8727E-53CC-4836-9CE5-91D119AB6924Q35666538-6F756E29-D1A4-4D15-AADA-6A5869FC11D9Q35672049-2FBAF93F-03D7-44AD-9CDC-516654E3740CQ35749531-6831FCE0-BC34-48B7-BAB7-CEF6B819128FQ35868880-E6F08F0E-42A1-4AC5-B7B6-C67371B59436Q35894852-85A4C97C-A043-4167-A7B1-DAF5C564C86AQ36200053-69BD0778-E23B-482F-95BB-A3961887312BQ36210416-5DB0EC4F-D2CC-4DC4-961F-1866BD3D01B6Q36259458-027BDF44-F0FC-477D-8439-D89E9D461336Q36426121-48793DA1-D87D-4FB7-A983-ECFB2BE3BDFAQ36442668-40B1DEA1-B3AB-49BD-97BE-551D129D6327
P2860
Bone metastasis: mechanisms and therapeutic opportunities.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bone metastasis: mechanisms and therapeutic opportunities.
@ast
Bone metastasis: mechanisms and therapeutic opportunities.
@en
Bone metastasis: mechanisms and therapeutic opportunities.
@nl
type
label
Bone metastasis: mechanisms and therapeutic opportunities.
@ast
Bone metastasis: mechanisms and therapeutic opportunities.
@en
Bone metastasis: mechanisms and therapeutic opportunities.
@nl
prefLabel
Bone metastasis: mechanisms and therapeutic opportunities.
@ast
Bone metastasis: mechanisms and therapeutic opportunities.
@en
Bone metastasis: mechanisms and therapeutic opportunities.
@nl
P2093
P2860
P356
P1476
Bone metastasis: mechanisms and therapeutic opportunities.
@en
P2093
Charity Washam
Larry J Suva
Richard W Nicholas
Robert J Griffin
P2860
P2888
P304
P356
10.1038/NRENDO.2010.227
P577
2011-01-04T00:00:00Z